That the 2018 Nobel Prize Award in Medicine was in part awarded to Tasuko Honjo for the discovery of PD-1 highlights the attention that this pathway has achieved abroad and in the clinic for treating cancer. This evidence concerns the gene PDCD1 and cancer.